Cargando…

Discovery of TIGIT inhibitors based on DEL and machine learning

Drug discovery has entered a new period of vigorous development with advanced technologies such as DNA-encoded library (DEL) and artificial intelligence (AI). The previous DEL-AI combination has been successfully applied in the drug discovery of classical kinase and receptor targets mainly based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Feng, Yu, Mingao, Xu, Honggui, Zhong, Zhenmin, Li, Zhenwei, Guo, Yuhan, Zhang, Tianyuan, Zeng, Zhixuan, Jin, Feng, He, Xun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360614/ https://www.ncbi.nlm.nih.gov/pubmed/35958238 http://dx.doi.org/10.3389/fchem.2022.982539

Ejemplares similares

3CLpro inhibitors: DEL-based molecular generation
por: Xiong, Feng, et al.
Publicado: (2022)

Materials Discovery With Machine Learning and Knowledge Discovery
por: Oliveira, Osvaldo N., et al.
Publicado: (2022)

Machine learning-driven new material discovery
por: Cai, Jiazhen, et al.
Publicado: (2020)

Discovery of Cobimetinib as a novel A-FABP inhibitor using machine learning and molecular docking-based virtual screening
por: Yang, Shilun, et al.
Publicado: (2022)

New strategy for clinical etiologic diagnosis of acute ischemic stroke and blood biomarker discovery based on machine learning
por: Zhang, Jin, et al.
Publicado: (2022)

Automatic discovery of photoisomerization mechanisms with nanosecond machine learning photodynamics simulations
por: Li, Jingbai, et al.
Publicado: (2021)

Discovery of new STAT3 inhibitors as anticancer agents using ligand-receptor contact fingerprints and docking-augmented machine learning
por: Jaradat, Nour Jamal, et al.
Publicado: (2023)

Differential expression of the T-cell inhibitor TIGIT in glioblastoma and MS
por: Lucca, Liliana E., et al.
Publicado: (2020)

Machine learning meets volcano plots: computational discovery of cross-coupling catalysts
por: Meyer, Benjamin, et al.
Publicado: (2018)

Use of Artificial Intelligence and Machine Learning for Discovery of Drugs for Neglected Tropical Diseases
por: Winkler, David A.
Publicado: (2021)

Collective variable discovery in the age of machine learning: reality, hype and everything in between
por: Bhakat, Soumendranath
Publicado: (2022)

Predictive chemistry: machine learning for reaction deployment, reaction development, and reaction discovery
por: Tu, Zhengkai, et al.
Publicado: (2022)

TIGIT in cancer immunotherapy
por: Chauvin, Joe-Marc, et al.
Publicado: (2020)

TIGIT Can Exert Immunosuppressive Effects on CD8(+) T Cells by the CD155/TIGIT Signaling Pathway for Hepatocellular Carcinoma In Vitro
por: Zhang, Changkun, et al.
Publicado: (2020)

TIGIT as a Novel Prognostic Marker for Immune Infiltration in Invasive Breast Cancer
por: Guo, Chenming, et al.
Publicado: (2023)

Development and validation of a novel blending machine learning model for hospital mortality prediction in ICU patients with Sepsis
por: Zeng, Zhixuan, et al.
Publicado: (2021)

Data-driven discovery of innate immunomodulators via machine learning-guided high throughput screening
por: Tang, Yifeng, et al.
Publicado: (2023)

Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning
por: Alabed, Shada J., et al.
Publicado: (2022)

Combination of Virtual Screening Protocol by in Silico toward the Discovery of Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors
por: Fu, Ying, et al.
Publicado: (2018)

Machine Learning for Discovery of GSK3β Inhibitors
por: Vignaux, Patricia A., et al.
Publicado: (2020)

Discovery of 2-Phenylquinoline-4-Carboxylic Acid Derivatives as Novel Histone Deacetylase Inhibitors
por: Hui, Qian, et al.
Publicado: (2022)

Development of a bispecific antibody targeting PD-L1 and TIGIT with optimal cytotoxicity
por: Zhong, Zhenwei, et al.
Publicado: (2022)

Discovery of new Cdc2-like kinase 4 (CLK4) inhibitors via pharmacophore exploration combined with flexible docking-based ligand/receptor contact fingerprints and machine learning
por: Al-Tawil, Mai Fayiz, et al.
Publicado: (2022)

TIGIT-based immunotherapeutics in lung cancer
por: Patel, Akshay J, et al.
Publicado: (2023)

DNAM1 and TIGIT balance the T cell response, with low T cell TIGIT expression corresponding to inflammation in psoriatic disease
por: Jacobs, Marleen E, et al.
Publicado: (2020)

Combining machine learning and structure-based approaches to develop oncogene PIM kinase inhibitors
por: Almukadi, Haifa, et al.
Publicado: (2023)

Dynamic Expressions of TIGIT on Splenic T Cells and TIGIT-Mediated Splenic T Cell Dysfunction of Mice With Chronic Toxoplasma gondii Infection
por: Li, Haoran, et al.
Publicado: (2021)

A machine learning protocol for revealing ion transport mechanisms from dynamic NMR shifts in paramagnetic battery materials
por: Lin, Min, et al.
Publicado: (2022)

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
por: Ren, Feng, et al.
Publicado: (2023)

Computation-accelerated discovery of the K(2)NiF(4)-type oxyhydrides combing density functional theory and machine learning approach
por: Bai, Qiang, et al.
Publicado: (2022)

Covalent inhibitors: a rational approach to drug discovery
por: Sutanto, Fandi, et al.
Publicado: (2020)

Discovery of Small Molecule Inhibitors Targeting the Sonic Hedgehog
por: Yun, Taikangxiang, et al.
Publicado: (2020)

Visualization-Based Discovery of Vanin-1 Inhibitors for Colitis
por: Wang, Guankai, et al.
Publicado: (2022)

Query-guided protein–protein interaction inhibitor discovery
por: Celis, Sergio, et al.
Publicado: (2021)

Mechanisms of TIGIT-driven immune suppression in cancer
por: Kurtulus, Sema, et al.
Publicado: (2014)

Expression of the immune checkpoint receptor TIGIT in seminoma
por: Hinsch, Andrea, et al.
Publicado: (2019)

Update in TIGIT Immune-Checkpoint Role in Cancer
por: Annese, Tiziana, et al.
Publicado: (2022)

TIGIT in Lung Cancer: Potential Theranostic Implications
por: Pescia, Carlo, et al.
Publicado: (2023)

Learning-accelerated discovery of immune-tumour interactions
por: Ozik, Jonathan, et al.
Publicado: (2019)

Benchmarking the acceleration of materials discovery by sequential learning
por: Rohr, Brian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oo1551bb7jd1ld80sepec89v13